Mark Shearman Insider Profile
4 Followers
Mark Shearman, EVP, CHIEF SCIENTIFIC OFFICER at Editas Medicine, holds 65.56K shares in Editas Medicine (Ticker: EDIT), holds 33.28K shares in Applied Genetic Technologies (Ticker: AGTC).
Mark Shearman's Trading History
| EDITEditas Medicine | Feb 15, 2023 | EVP, CHIEF SCIENTIFIC OFFICER | Uninformative Sell | 26.95K | $142.26K | |
| AGTCApplied Genetic Technologies | Aug 18, 2020 | ― | Uninformative Sell | 33.02K | $13.08K |
You May Also Like
Mark Shearman insider profile FAQ
What is the percentage of profitable transactions made by Mark Shearman?
The percentage of profitable transactions made by Mark Shearman is 50%.
What is the average return per transaction made by Mark Shearman?
The average return per transaction made by Mark Shearman is -28.30%.
What stocks does Mark Shearman hold?
Mark Shearman holds: EDIT, AGTC stocks.
What was Mark Shearman’s latest transaction?
Mark Shearman’s latest transaction was an Uninformative Sell of $26.95K.
What was Mark Shearman's most profitable transaction?
Mark Shearman’s most profitable transaction was an Informative Sell of AGTC stock on December 18, 2018. The return on the trade was 2.40%.
What is Mark Shearman's role in Editas Medicine?
Mark Shearman's role in Editas Medicine is EVP, CHIEF SCIENTIFIC OFFICER.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
